tiprankstipranks
4D Molecular Therapeutics, Inc. (FDMT)
:FDMT
US Market

4D Molecular Therapeutics (FDMT) Income Statement

Compare
339 Followers

4D Molecular Therapeutics Income Statement

Last quarter (Q3 2024), 4D Molecular Therapeutics's total revenue was $3.00K, a decrease of -99.99% from the same quarter last year. In Q3, 4D Molecular Therapeutics's net income was $-43.84M. See 4D Molecular Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 20.72M$ 3.13M$ 18.04M$ 13.61M$ 6.99M
Gross Profit
$ -76.37M$ -751.00K$ 15.02M$ -39.43M$ -31.73M
Operating Expenses
$ 133.59M$ 113.16M$ 89.37M$ 70.28M$ 52.61M
Depreciation and Amortization
$ 5.75M$ 3.88M$ 3.02M$ 1.44M$ 1.00M
EBITDA
$ -107.12M$ -106.15M$ -68.31M$ -55.22M$ -44.62M
Operating Income
$ -112.87M$ -110.03M$ -71.33M$ -56.66M$ -50.76M
Other Income/Expenses
$ 12.03M$ 2.54M$ 16.00K$ -29.00K$ 1.46M
Pretax Income
$ -100.84M$ -107.49M$ -71.32M$ -56.69M$ -49.31M
Net Income
$ -100.84M$ -101.08M$ -68.30M$ -56.54M$ -52.94M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.58$ -3.12$ -2.46$ -2.12$ -2.00
Diluted EPS
$ -2.58$ -3.12$ -2.46$ -2.12$ -2.00
Weighted Average Shares Outstanding
39.13M 32.35M 27.73M 26.68M 26.49M
Weighted Average Shares Outstanding (Diluted)
39.13M 32.35M 27.73M 26.68M 26.49M
Currency in USD

4D Molecular Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis